# Additional Anti-emetic Effect of Ramosetron Prophylaxis After Total Knee Arthroplasty

> **NCT01102491** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 153 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** Ramosetron

## Key facts

- **NCT ID:** NCT01102491
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-02
- **Final completion:** 2010-03
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2012-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01102491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01102491, "Additional Anti-emetic Effect of Ramosetron Prophylaxis After Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01102491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*